BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25641682)

  • 1. Epigenetic regulation contributes to urocortin-enhanced midbrain dopaminergic neuron differentiation.
    Huang HY; Chiu TL; Chang HF; Hsu HR; Pang CY; Liew HK; Wang MJ
    Stem Cells; 2015 May; 33(5):1601-17. PubMed ID: 25641682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foxa2 acts as a co-activator potentiating expression of the Nurr1-induced DA phenotype via epigenetic regulation.
    Yi SH; He XB; Rhee YH; Park CH; Takizawa T; Nakashima K; Lee SH
    Development; 2014 Feb; 141(4):761-72. PubMed ID: 24496614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications.
    He XB; Yi SH; Rhee YH; Kim H; Han YM; Lee SH; Lee H; Park CH; Lee YS; Richardson E; Kim BW; Lee SH
    Stem Cells; 2011 Nov; 29(11):1861-73. PubMed ID: 21922608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibition mediates urocortin-induced antiproliferation and neuronal differentiation in neural stem cells.
    Huang HY; Liu DD; Chang HF; Chen WF; Hsu HR; Kuo JS; Wang MJ
    Stem Cells; 2012 Dec; 30(12):2760-73. PubMed ID: 22961741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Ezh2 In Vitro and the Decline of
    Hong F; Zhao M; Zhang L; Feng L
    Stem Cells Dev; 2019 May; 28(10):649-658. PubMed ID: 30887911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic activation of the Foxa2 gene is required for maintaining the potential of neural precursor cells to differentiate into dopaminergic neurons after expansion.
    Bang SY; Kwon SH; Yi SH; Yi SA; Park EK; Lee JC; Jang CG; You JS; Lee SH; Han JW
    Stem Cells Dev; 2015 Feb; 24(4):520-33. PubMed ID: 25233056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.
    Green AL; Zhan L; Eid A; Zarbl H; Guo GL; Richardson JR
    Neuropharmacology; 2017 Oct; 125():189-196. PubMed ID: 28743636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons.
    Edman LC; Mira H; Arenas E
    Exp Cell Res; 2008 Jun; 314(10):2123-30. PubMed ID: 18420193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin modulates dopaminergic neuronal survival via inhibition of glycogen synthase kinase-3β and histone deacetylase.
    Huang HY; Lin SZ; Chen WF; Li KW; Kuo JS; Wang MJ
    Neurobiol Aging; 2011 Sep; 32(9):1662-77. PubMed ID: 19875195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease.
    Lei Z; Jiang Y; Li T; Zhu J; Zeng S
    J Neuropathol Exp Neurol; 2011 Sep; 70(9):736-47. PubMed ID: 21865882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival.
    Lee HS; Bae EJ; Yi SH; Shim JW; Jo AY; Kang JS; Yoon EH; Rhee YH; Park CH; Koh HC; Kim HJ; Choi HS; Han JW; Lee YS; Kim J; Li JY; Brundin P; Lee SH
    Stem Cells; 2010 Mar; 28(3):501-12. PubMed ID: 20049900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed dopaminergic neuron differentiation in Lrp6 mutant mice.
    Castelo-Branco G; Andersson ER; Minina E; Sousa KM; Ribeiro D; Kokubu C; Imai K; Prakash N; Wurst W; Arenas E
    Dev Dyn; 2010 Jan; 239(1):211-21. PubMed ID: 19795519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bdnf gene is a downstream target of Nurr1 transcription factor in rat midbrain neurons in vitro.
    Volpicelli F; Caiazzo M; Greco D; Consales C; Leone L; Perrone-Capano C; Colucci D'Amato L; di Porzio U
    J Neurochem; 2007 Jul; 102(2):441-53. PubMed ID: 17506860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression.
    Jacobs FM; van Erp S; van der Linden AJ; von Oerthel L; Burbach JP; Smidt MP
    Development; 2009 Feb; 136(4):531-40. PubMed ID: 19144721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro regulated expression of tyrosine hydroxylase in ventral midbrain neurons from Nurr1-null mouse pups.
    Eells JB; Rives JE; Yeung SK; Nikodem VM
    J Neurosci Res; 2001 May; 64(4):322-30. PubMed ID: 11340638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of nuclear fibroblast growth factor receptor 1 and Nurr1 offers new interactive mechanism in postmitotic development of mesencephalic dopaminergic neurons.
    Baron O; Förthmann B; Lee YW; Terranova C; Ratzka A; Stachowiak EK; Grothe C; Claus P; Stachowiak MK
    J Biol Chem; 2012 Jun; 287(24):19827-40. PubMed ID: 22514272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional roles of Nurr1, Pitx3, and Lmx1a in neurogenesis and phenotype specification of dopamine neurons during in vitro differentiation of embryonic stem cells.
    Hong S; Chung S; Leung K; Hwang I; Moon J; Kim KS
    Stem Cells Dev; 2014 Mar; 23(5):477-87. PubMed ID: 24172139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Nurr1 and Ret in inducing rat embryonic neural precursors to dopaminergic neurons.
    Li L; Su Y; Zhao C; Xu Q
    Neurol Res; 2009 Jun; 31(5):534-40. PubMed ID: 19133164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages.
    Stott SR; Metzakopian E; Lin W; Kaestner KH; Hen R; Ang SL
    J Neurosci; 2013 May; 33(18):8022-34. PubMed ID: 23637192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specification of dopaminergic subsets involves interplay of En1 and Pitx3.
    Veenvliet JV; Dos Santos MT; Kouwenhoven WM; von Oerthel L; Lim JL; van der Linden AJ; Koerkamp MJ; Holstege FC; Smidt MP
    Development; 2013 Aug; 140(16):3373-84. PubMed ID: 23863478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.